PRMT5 and cancer: PRMT5 is also a major regulator of genome stability and HR-mediated DSB repair, with depletion or inhibition sensitising cancer cells to chemotherapeutic DNA-damaging agents including cisplatin and radiotherapy [20, 24, 32].